Singapore: +65-85097465 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Zimbabwe: +263-735539685, 773876488

          

Clinical Trial News

Study and clinical trial aim to identify biomarkers and provide clues into individual treatment response for locally advanced pancreatic cancer

Investigators at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute are developing a novel, multistep investigational treatment for one of the most complex and difficult-to-treat forms of...

Blood thinning drug safety concerns exposed

The safety of the blood thinning drug dabigatran (Pradaxa) has been challenged in an investigation by the BMJ, as has the evidence that led to the drug's approval by regulators.

Seven pharma companies offer up compounds to UK researchers

UK researchers will be granted access to a 'virtual library' of deprioritised pharmaceutical compounds through a new partnership between the Medical Research Council (MRC) and seven global drug...

Could a single injection stop diabetes?

Researchers who gave mice with type 2 diabetes the growth factor FGF1, found it reversed diabetes and kept blood glucose within a safe range for 2 days with just one injection.

Study reveals a need for transparency in clinical trials

[ML:STORY]

Asthma medication linked to growth suppression in children

A review of past studies has found that inhaled corticosteroids used to treat asthma could result in restricting the growth of children who have the condition.

ANAVEX 3-71 highly effective and disease-modifying against all major Alzheimer's hallmarks in preclinical disease model

Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's disease, other diseases of the central nervous system (CNS) and various...

CellAct Pharma receives orphan drug designation in EU for CAP7.1 in biliary tract cancers

CellAct Pharma, a developer of innovative treatments for cancer, has announced that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has granted orphan drug...



James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook